For decades, people with psoriasis have been treated in clinics with narrowband ultraviolet B phototherapy, or light therapy, ...

Nail psoriasis is common in patients with plaque psoriasis and is associated with morbidity, including onychomycosis, which ...

Johnson & Johnson's Tremfya showed significant skin clearance in adults with low BSA moderate plaque psoriasis in the ...

Nail fungus and nail psoriasis have similar symptoms, and you could have both at the same time. Learn how to spot the signs ...

(RTTNews) - Johnson & Johnson (JNJ) Friday announced positive results from Phase 3b SPECTREM study of Tremfya to treat adults with low body surface area (BSA) moderate plaque psoriasis (PsO) in ...

Could home-based phototherapy for plaque or guttate psoriasis be just as effective as office-based treatment? Find out ...

New phase 3b data reveal significant skin clearance in historically underserved patients with moderate plaque psoriasis, offering hope for improved treatment outcomes.

J&J said its latest TV ad, which highlights the psoriasis experience among people of color, is part of its broader effort to ...

Psoriasis is a skin condition that causes the formation of thick, scaly patches on the body. It’s commonly found on the ...

In a systematic review, the incidence of gastrointestinal-related adverse events associated with the use of biologic therapies for psoriasis was 8.7%.

The use of IL-17 inhibitors in patients with psoriasis was associated with an increased risk for fungal infections when compared with other biologics.

Nail psoriasis is common in patients with plaque psoriasis and is associated with morbidity, including onychomycosis, which can complicate psoriasis ...